
Recent Articles
Plastic Straw Ban 2018: California First State to Limit Restaurant Use
By
Karl Utermohlen, InvestorPlace Writer
California has become the first state to implement a partial plastic straw ban on full-service restaurants. Here's what consuers should know.
Steelcase Stock Soars on Q2 Profit, Revenue Beat
By
Karl Utermohlen, InvestorPlace Writer
Steelcase stock (SCS) was up more than 11% on Thursday after hours as the company's earnings and revenue topped Wall Street's expectations.
Micron Stock Surges on Q4 Earnings, Revenue Beat
By
Karl Utermohlen, InvestorPlace Writer
Micron stock (MU) was up over 4% after the bell Thursday as the company reported its latest quarterly earnings results, which beat estimates.
Athleta for Men? 7 Things to Know About Gap’s New Hill City Brand
By
Karl Utermohlen, InvestorPlace Writer
Gap (GPS) announced Hill City, an athleisure line for men that is similar to its Athleta brand for women. Here's what you should know.
GE Stock Is Slipping Today on Turbine Issue
By
Karl Utermohlen, InvestorPlace Writer
General Electric (NYSE:GE) stock was down nearly 3% as the company announced that four of its power turbines are having issues with their blades. The…
Eventbrite IPO: EB Stock at $36 Out of the Gate
By
Karl Utermohlen, InvestorPlace Writer
The Eventbrite IPO took place today and it opened at $36 per share and shares soared more than 60% in its debut. Shares are at around $38.
Moe’s Free Queso Day: What to Do to Get Yours
By
Karl Utermohlen, InvestorPlace Writer
Moe's is offering a Free Queso Day on Thursday, Sept. 20 all day. All you have to do is show up at a Moe's location and get chips and queso.
Herman Miller Stock Skyrockets on Q1 Earnings Beat
By
Karl Utermohlen, InvestorPlace Writer
Herman Miller (MLHR) reported its latest quarterly earnings results on Wednesday, sending shares soaring as the company topped expectations.
Red Hat Earnings: 6 Things to Know About Q2
By
Karl Utermohlen, InvestorPlace Writer
Red Hat earnings (RHT) were released on Wednesday and the company topped earnings expectations but missed the mark on its revenue totals.
Why Altimmune Stock Is Skyrocketing Today
By
Karl Utermohlen, InvestorPlace Writer
Altimmune stock (ALT) soared more than 285% following successful clinical trial data of a medication and a reverse split of common shares.

Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.